Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
GRCh37/hg19 1q31.3(chr1:195001536-195019464)x1			not provided	Benign(Last reviewed: Mar 27, 2012)	no assertion criteria provided	VCV000612662	1	195001536 - 195019464			612662	603998		
Single allele	ATP10A|NPAP1|CYFIP1|SNURF|GOLGA6L2|SNORD115-1|SNORD116-1|PWRN2|MAGEL2|TUBGCP5|NIPA1|PWAR1|NDN|SNRPN|NIPA2|PWRN1|GABRB3|PWARSN|PWAR6|UBE3A|OCA2|MKRN3|PWAR4|IPW|GABRA5|GABRG3|PWAR5|HERC2		Angelman syndrome	Pathogenic(Last reviewed: Jun 19, 2018)	criteria provided, single submitter	VCV000974577	15	22833416 - 28566671			974577	962874		
GRCh37/hg19 15q11.2-13.1(chr15:22816713-28530182)	ATP10A|CYFIP1|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625832	15	22816713 - 28530182			625832	614136		
GRCh37/hg19 15q11.2-13.1(chr15:23810184-28525505)	ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625718	15	23810184 - 28525505			625718	614022		
GRCh37/hg19 15q11.2-13.1(chr15:23683783-28530182)	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625717	15	23683783 - 28530182			625717	614021		
GRCh37/hg19 15q11.2-13.1(chr15:23615768-28561671)	ATP10A|GABRA5|GABRB3|GABRG3|GOLGA6L2|HERC2|IPW|MAGEL2|MKRN3|NDN|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625716	15	23615768 - 28561671			625716	614020		
GRCh37/hg19 15q11.2-13.1(chr15:22770994-29050198)	ATP10A|CYFIP1|GABRA5|IPW|GABRB3|GABRG3|GOLGA6L2|GOLGA8M|HERC2|MAGEL2|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TUBGCP5|UBE3A		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625713	15	22770994 - 29050198			625713	614017		
GRCh38/hg38 15q11.2-13.1(chr15:23999707-28314256)x1	ATP10A|ATP10A-DT|GABRA5|GABRB3|GABRG3|GABRG3-AS1|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC112272578|LOC112272579|LOC112272580|MIR4715|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|UBE3A		See cases	Pathogenic(Last reviewed: Jul 2, 2012)	no assertion criteria provided	VCV000150851	15	24244854 - 28557186	15	23999707 - 28314256	150851	160602		
GRCh38/hg38 15q11.2-13.1(chr15:22358243-28481444)x1	ATP10A|ATP10A-DT|CYFIP1|GABRA5|GABRB3|GABRG3|GABRG3-AS1|GOLGA6L1|GOLGA6L2|GOLGA6L22|GOLGA8F|GOLGA8S|HERC2|IPW|LINC00929|LINC02250|LINC02346|LOC102723623|LOC112272575|LOC112272576|LOC112272578|LOC112272579|LOC112272580|LOC283683|LOC645202|MAGEL2|MIR4508|MIR4509-1|MIR4509-2|MIR4715|MKRN3|NDN|NIPA1|NIPA2|NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|PWRN3|PWRN4|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-10|SNORD115-11|SNORD115-12|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-19|SNORD115-2|SNORD115-20|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|TRE-TTC2-2|TUBGCP5|UBE3A		See cases	Pathogenic(Last reviewed: Dec 22, 2010)	no assertion criteria provided	VCV000033590	15	22698522 - 29030517	15	22358243 - 28481444	33590	42255		
GRCh37/hg19 13q12.13(chr13:26248721-26359860)x1	ATP8A2		See cases	Uncertain significance(Last reviewed: Sep 12, 2011)	no assertion criteria provided	VCV000150151	13	26248721 - 26359860	13	53472 - 158085	150151	159902		
GRCh38/hg38 15q11.2(chr15:22572809-23066575)x1	CYFIP1|LOC112272575|LOC112272576|LOC283683|NIPA1|NIPA2|TUBGCP5		See cases	Conflicting interpretations of pathogenicity(Last reviewed: Jul 18, 2014)	no assertion criteria provided	VCV000144192	15	22765628 - 23300287	15	22572809 - 23066575	144192	153943		
GRCh37/hg19 15q11.2-13.1(chr15:23616095-28538904)x1	GABRA5|GABRB3|GABRG3|IPW|NDN|OCA2|SNRPN|UBE3A|MKRN3|PWAR5|HERC2|SNURF|NPAP1|MAGEL2|ATP10A|PWAR1|GOLGA6L2|SNORD115-1|PWAR4|PWARSN|PWRN1|PWRN2|SNORD116-1|PWAR6		not provided	Pathogenic(Last reviewed: Jan 6, 2020)	criteria provided, single submitter	VCV001180527	15	23616095 - 28538904			1180527	1170075		
GRCh37/hg19 15q11.2-13.3(chr15:20848750-32925141)	GABRA5|GABRB3|GABRG3|GOLGA6L1|GOLGA6L2|GOLGA8H|GOLGA8J|GOLGA8M|GOLGA8N|GOLGA8O|HERC2|IPW|KLF13|MAGEL2|MIR211|MKRN3|MTMR10|NDN|NIPA1|NIPA2|NPAP1|NSMCE3|OCA2|OR4M2|OR4N4|OTUD7A|POTEB|POTEB2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|PWRN2|SNORD115-1|SNORD116-1|SNRPN|SNURF|TJP1|TRPM1|TUBGCP5|UBE3A|APBA2|ARHGAP11A|ARHGAP11B|ATP10A|CHRFAM7A|CHRNA7|CYFIP1|FAM189A1|FAN1		Prader-Willi syndrome|Angelman syndrome	Pathogenic(Last reviewed: Nov 1, 2018)	criteria provided, single submitter	VCV000625711	15	20848750 - 32925141			625711	614015		
Single allele	HERC2|MKRN3|SNURF|GABRB3|PWAR1|GABRG3|PWRN1|MAGEL2|IPW|SNRPN|PWAR6|SNORD116-1|PWARSN|OCA2|GABRA5|PWAR4|NDN|ATP10A|PWAR5|SNORD115-1|PWRN2|NPAP1|UBE3A		Prader-Willi syndrome	Pathogenic	criteria provided, single submitter	VCV000375417	15	23707435 - 28520316			375417	362184		
NM_019066.5(MAGEL2):c.509_510delinsTG (p.Ala170Val)	MAGEL2	A170V	Schaaf-Yang syndrome	Uncertain significance(Last reviewed: Jul 3, 2020)	criteria provided, single submitter	VCV001184373	15	23892380 - 23892381	15	23647233 - 23647234	1184373	1174176		NC_000015.10:23647232:GG:CA
NM_019066.5(MAGEL2):c.2646del (p.Gly883fs)	MAGEL2	G883fs	Schaaf-Yang syndrome	Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, single submitter	VCV001098311	15	23890244	15	23645097	1098311	1087013		NC_000015.10:23645096:GG:G
NM_019066.5(MAGEL2):c.648del (p.Thr217fs)	MAGEL2	T217fs	Schaaf-Yang syndrome	Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, single submitter	VCV001098310	15	23892242	15	23647095	1098310	1087016		NC_000015.10:23647094:CCCC:CCC
NM_019066.5(MAGEL2):c.3583del (p.Met1195fs)	MAGEL2	M1195fs	Schaaf-Yang syndrome	Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, single submitter	VCV001098308	15	23889307	15	23644160	1098308	1087012		NC_000015.10:23644159:T:
NM_019066.5(MAGEL2):c.2847_2883del (p.Ser950fs)	MAGEL2	S950fs	not provided|Schaaf-Yang syndrome	Pathogenic/Likely pathogenic(Last reviewed: May 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000986880	15	23890007 - 23890043	15	23644860 - 23644896	986880	975404		NC_000015.10:23644859:GGGCCCTTCCCAGCCACTCAGGATCCTGGAGGTGCTAGGGCCCT:GGGCCCT
NM_019066.5(MAGEL2):c.1601del (p.Pro534fs)	MAGEL2	P534fs	Schaaf-Yang syndrome|Inborn genetic diseases	Pathogenic(Last reviewed: Jan 31, 2019)	criteria provided, single submitter	VCV000973031	15	23891289	15	23646142	973031	961320		NC_000015.10:23646141:GGGG:GGG
NM_019066.5(MAGEL2):c.539_568del (p.Val180_Met189del)	MAGEL2		Prader-Willi syndrome	Uncertain significance(Last reviewed: Mar 27, 2019)	criteria provided, single submitter	VCV000931010	15	23892322 - 23892351	15	23647175 - 23647204	931010	919557		NC_000015.10:23647174:CCATCGGGGTCCCCGGAGGAGGAGGATGCACCATCGGGGTCCCCGGAGGAGGAGGATG:CCATCGGGGTCCCCGGAGGAGGAGGATG
NM_019066.5(MAGEL2):c.3246del (p.Asn1084fs)	MAGEL2	N1084fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Feb 14, 2019)	criteria provided, single submitter	VCV000816928	15	23889644	15	23644497	816928	805104	rs1595331427	NC_000015.10:23644496:GG:G
NM_019066.5(MAGEL2):c.2199del (p.Glu734fs)	MAGEL2	E734fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803054	15	23890691	15	23645544	803054	791431	rs1595332359	NC_000015.10:23645543:TTT:TT
NM_019066.5(MAGEL2):c.2118del (p.Leu708fs)	MAGEL2	L708fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Sep 26, 2017)	no assertion criteria provided	VCV000440464	15	23890772	15	23645625	440464	434102	rs1555374227	NC_000015.10:23645624:AAAA:AAA
NM_019066.5(MAGEL2):c.1996del (p.Gln666fs)	MAGEL2	Q666fs	Schaaf-Yang syndrome|Ambiguous genitalia|Generalized hypotonia|Multiple joint contractures|Ventriculomegaly|not provided	Pathogenic(Last reviewed: Aug 4, 2020)	criteria provided, multiple submitters, no conflicts	VCV000440463	15	23890894	15	23645747	440463	434101	rs770374710	NC_000015.10:23645746:GGGGGGG:GGGGGG
NM_019066.5(MAGEL2):c.2958del (p.Ser987fs)	MAGEL2	S987fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Mar 9, 2017)	criteria provided, single submitter	VCV000403667	15	23889932	15	23644785	403667	390647	rs1060499934	NC_000015.10:23644784:CCC:CC
NM_019066.5(MAGEL2):c.1802del (p.Pro601fs)	MAGEL2	P601fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Sep 1, 2017)	criteria provided, single submitter	VCV000089001	15	23891088	15	23645941	89001	94555	rs398122416	NC_000015.10:23645940:GG:G
NM_019066.5(MAGEL2):c.1652del (p.Val551fs)	MAGEL2	V551fs	Schaaf-Yang syndrome	Pathogenic(Last reviewed: Nov 1, 2013)	no assertion criteria provided	VCV000089000	15	23891238	15	23646091	89000	94554	rs398122415	NC_000015.10:23646090:A:
NM_001110792.2(MECP2):c.1195_1246del (p.Pro399fs)	MECP2	P387fs, P294fs, P399fs, P164fs	Angelman syndrome|Atypical Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000189662	X	153296069 - 153296120	X	154030618 - 154030669	189662	187486	rs1557135251	
NM_001110792.2(MECP2):c.1197_1202del (p.Pro402_Pro403del)	MECP2		Angelman syndrome|not provided	Likely benign(Last reviewed: Dec 21, 2020)	criteria provided, single submitter	VCV000143390	X	153296113 - 153296118	X	154030662 - 154030667	143390	153122	rs267608332	NC_000023.11:154030661:GGTGGGGG:GG
NM_001110792.2(MECP2):c.1193_1236del (p.Leu398fs)	MECP2	L398fs, L293fs, L163fs	Angelman syndrome|not provided|Severe neonatal-onset encephalopathy with microcephaly|Rett syndrome	Pathogenic(Last reviewed: Oct 23, 2020)	criteria provided, multiple submitters, no conflicts	VCV000143372	X	153296079 - 153296122	X	154030628 - 154030671	143372	153104	rs63749748	NC_000023.11:154030627:GGTGGGGTCCTCGGAGCTCTCGGGCTCAGGTGGAGGTGGGGGCAGG:GG
NM_001110792.2(MECP2):c.203_204del (p.Pro68fs)	MECP2	P56fs, P68fs	Angelman syndrome|Rett syndrome	Pathogenic(Last reviewed: Apr 10, 2002)	no assertion criteria provided	VCV000011818	X	153297867 - 153297868	X	154032416 - 154032417	11818	26857	rs267608434	NC_000023.11:154032415:GGG:G
GRCh37/hg19 15q11.2(chr15:22750305-23702085)x1	NIPA1|GOLGA6L2|NIPA2|TUBGCP5|CYFIP1		See cases	Uncertain significance(Last reviewed: Jan 7, 2016)	criteria provided, single submitter	VCV000221995	15	22750305 - 23702085			221995	223683		
NC_000015.9:g.(?_23730704)_(28530182_?)del	NPAP1|OCA2|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|SNORD115-1|SNORD116-1|SNRPN|PWRN1|PWRN2|ATP10A|GABRA5|GABRB3|GABRG3|HERC2|IPW|MAGEL2|MKRN3|NDN|SNURF|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Aug 21, 2013)	criteria provided, single submitter	VCV000209214	15	23730704 - 28530182			209214	205805		
Single allele	OCA2|SNORD115-1|SNORD116-1|GOLGA6L2|SNURF|ATP10A|PWARSN|MAGEL2|PWAR1|PWAR6|GABRA5|UBE3A|GABRG3|NPAP1|GABRB3|MKRN3|PWRN2|PWAR4|NDN|IPW|PWRN1|HERC2|SNRPN|PWAR5		Angelman syndrome	Pathogenic(Last reviewed: Nov 2, 2018)	criteria provided, single submitter	VCV000974578	15	23579300 - 28447626			974578	962875		
Single allele	PWARSN|PWAR4|GABRA5|GABRB3|CYFIP1|NIPA2|SNURF|MKRN3|PWAR1|SNORD115-1|SNORD116-1|GOLGA6L1|OCA2|MAGEL2|IPW|NIPA1|PWRN2|PWRN1|HERC2|ATP10A|PWAR5|NDN|NPAP1|UBE3A|GABRG3|PWAR6|GOLGA6L2|SNRPN|TUBGCP5|GOLGA8M		Angelman syndrome	Pathogenic(Last reviewed: Nov 24, 2017)	criteria provided, single submitter	VCV000974576	15	22646692 - 28964445			974576	962873		
NM_005068.3(SIM1):c.-200del	SIM1		Schaaf-Yang syndrome	Uncertain significance(Last reviewed: Jun 14, 2016)	criteria provided, single submitter	VCV000354690	6	100911544	6	100463668	354690	305161	rs146022425	NC_000006.12:100463667:AAAA:AAA
NM_130839.5(UBE3A):c.1402del (p.Thr468fs)	SNHG14|UBE3A	T409fs, T468fs, T448fs, T471fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 18, 2018)	criteria provided, single submitter	VCV001032380	15	25615919	15	25370772	1032380	1021283		NC_000015.10:25370771:TTT:TT
NM_000462.3:c.2365delG	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Dec 1, 2020)	criteria provided, single submitter	VCV000995996	15	25585374	15	25340227	995996	983697		NC_000015.10:25340226:CCC:CC
NM_130839.5(UBE3A):c.2124+6_2124+9del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Mar 20, 2020)	criteria provided, single submitter	VCV000951417	15	25601030 - 25601033	15	25355883 - 25355886	951417	941079		NC_000015.10:25355882:ATTTATT:ATT
NM_130839.5(UBE3A):c.2344_2345del (p.Val782fs)	SNHG14|UBE3A	V345fs, V710fs, V762fs, V365fs, V707fs, V785fs, V723fs, V782fs, V730fs	Angelman syndrome	Pathogenic(Last reviewed: Aug 29, 2019)	criteria provided, single submitter	VCV000934588	15	25599509 - 25599510	15	25354362 - 25354363	934588	936829		NC_000015.10:25354361:ACA:A
NM_130839.5(UBE3A):c.1405_1408del (p.Glu469fs)	SNHG14|UBE3A	E469fs, E410fs, E449fs, E472fs	Angelman syndrome	Likely pathogenic(Last reviewed: May 28, 2019)	criteria provided, single submitter	VCV000803058	15	25615913 - 25615916	15	25370766 - 25370769	803058	791435	rs587784512	NC_000015.10:25370765:TCTCT:T
NM_130839.5(UBE3A):c.1322del (p.Ile441fs)	SNHG14|UBE3A	I421fs, I444fs, I382fs, I441fs	Angelman syndrome	Pathogenic(Last reviewed: Sep 28, 2018)	criteria provided, single submitter	VCV000645339	15	25615999	15	25370852	645339	642998	rs1595804239	NC_000015.10:25370851:A:
NC_000015.10:g.(?_25375445)_(25375783_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 5, 2018)	criteria provided, single submitter	VCV000584072	15	25620592 - 25620930	15	25375445 - 25375783	584072	568563		
NC_000015.10:g.(?_25354333)_(25360547_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 23, 2018)	criteria provided, single submitter	VCV000583861	15	25599480 - 25605694	15	25354333 - 25360547	583861	569188		
NC_000015.10:g.(?_25360363)_(25360547_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jun 29, 2018)	criteria provided, single submitter	VCV000583413	15	25605510 - 25605694	15	25360363 - 25360547	583413	569191		
NM_130839.5(UBE3A):c.1678_1699delinsT (p.Gln560_Val567delinsPhe)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Aug 13, 2019)	criteria provided, single submitter	VCV000571267	15	25605584 - 25605605	15	25360437 - 25360458	571267	569216	rs1566912450	NC_000015.10:25360436:CACCTCCCTCATCAACTCCTTG:A
NM_130839.5(UBE3A):c.1600del (p.Val535fs)	SNHG14|UBE3A	V476fs, V515fs, V538fs, V535fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 14, 2018)	criteria provided, single submitter	VCV000568584	15	25615721	15	25370574	568584	569219	rs1566954070	NC_000015.10:25370573:G:
NM_130839.5(UBE3A):c.2406_2414del (p.Leu803_Phe805del)	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Jul 18, 2017)	criteria provided, single submitter	VCV000458666	15	25585316 - 25585324	15	25340169 - 25340177	458666	464802	rs1555380809	NC_000015.10:25340168:AACTGCAAGAA:AA
NC_000015.10:g.(?_25339117)_(25409127_?)del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Dec 23, 2019)	criteria provided, single submitter	VCV000458663			15	25339117 - 25409127	458663	464761		
NM_130839.5(UBE3A):c.2535_2551del (p.Leu846fs)	SNHG14|UBE3A	L409fs, L771fs, L774fs, L429fs, L849fs, L826fs, L787fs, L794fs, L846fs	Angelman syndrome	Pathogenic(Last reviewed: Jun 17, 2016)	criteria provided, single submitter	VCV000408432	15	25584352 - 25584368	15	25339205 - 25339221	408432	400542	rs1064792950	NC_000015.10:25339204:TTGAGTATTCCGGAAGT:
NM_130839.5(UBE3A):c.2553_2569del (p.Ser851fs)	SNHG14|UBE3A	S414fs, S434fs, S776fs, S792fs, S831fs, S851fs, S779fs, S799fs, S854fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 5, 2016)	criteria provided, single submitter	VCV000375262	15	25584334 - 25584350	15	25339187 - 25339203	375262	361963	rs1057519062	NC_000015.10:25339186:CTTTAAGTTTTTCTTTGCTT:CTT
NM_130838.1(UBE3A):c.-44_*1888del	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Sep 11, 2016)	criteria provided, single submitter	VCV000241833	15	25582396 - 25650653	15	25337249 - 25405506	241833	242023		
NM_130839.5(UBE3A):c.1871_1872del (p.Cys624fs)	SNHG14|UBE3A	C187fs, C207fs, C565fs, C604fs, C624fs, C627fs	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Sep 8, 2014)	criteria provided, single submitter	VCV000218320	15	25601925 - 25601926	15	25356778 - 25356779	218320	215013	rs864309508	NC_000015.10:25356777:ACA:A
NM_130839.5(UBE3A):c.2563_2568del (p.Leu855_Lys856del)	SNHG14|UBE3A		Angelman syndrome|not provided	Conflicting interpretations of pathogenicity(Last reviewed: Aug 24, 2019)	criteria provided, conflicting interpretations	VCV000217365	15	25584335 - 25584340	15	25339188 - 25339193	217365	196435	rs863225070	NC_000015.10:25339187:TTTAAGTTT:TTT
NM_130839.5(UBE3A):c.2535_2538del (p.Leu845fs)	SNHG14|UBE3A	L773fs, L770fs, L408fs, L428fs, L825fs, L845fs, L786fs, L793fs, L848fs	Angelman syndrome	Likely pathogenic(Last reviewed: Nov 5, 2013)	criteria provided, single submitter	VCV000217026	15	25584365 - 25584368	15	25339218 - 25339221	217026	213632	rs863224940	NC_000015.10:25339217:AAGTAA:AA
NM_130839.5(UBE3A):c.63-14_63-7del	SNHG14|UBE3A		not provided|Angelman syndrome	Uncertain significance(Last reviewed: Mar 24, 2021)	reviewed by expert panel	VCV000195397	15	25620917 - 25620924	15	25375770 - 25375777	195397	192558	rs794727306	NC_000015.10:25375769:CAAACATTCAAACA:CAAACA
NM_130839.5(UBE3A):c.565_571del (p.Glu189fs)	SNHG14|UBE3A	E130fs, E169fs, E189fs, E192fs	Angelman syndrome	Pathogenic(Last reviewed: Dec 3, 2013)	criteria provided, single submitter	VCV000160226	15	25616750 - 25616756	15	25371603 - 25371609	160226	169102	rs587784532	NC_000015.10:25371602:CCTTTTC:
NM_130839.5(UBE3A):c.448_459del (p.Ile150_Val153del)	SNHG14|UBE3A		Angelman syndrome	Likely pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160225	15	25616862 - 25616873	15	25371715 - 25371726	160225	169103	rs587784531	NC_000015.10:25371714:AACTCTTCCAATAAC:AAC
NM_130839.5(UBE3A):c.440del (p.Ile147fs)	SNHG14|UBE3A	I127fs, I147fs, I150fs, I88fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160224	15	25616881	15	25371734	160224	169104	rs587784530	NC_000015.10:25371733:A:
NM_130839.5(UBE3A):c.377_381del (p.Thr126fs)	SNHG14|UBE3A	T129fs, T106fs, T126fs, T67fs	not provided|Angelman syndrome	Pathogenic(Last reviewed: May 14, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160223	15	25616940 - 25616944	15	25371793 - 25371797	160223	169105	rs587784529	NC_000015.10:25371792:TTCTGTT:TT
NM_130839.5(UBE3A):c.2567_2570del (p.Lys856fs)	SNHG14|UBE3A	K859fs, K419fs, K439fs, K781fs, K797fs, K784fs, K804fs, K836fs, K856fs	Intellectual disability|History of neurodevelopmental disorder|Inborn genetic diseases|Angelman syndrome|not provided	Pathogenic(Last reviewed: Mar 26, 2021)	reviewed by expert panel	VCV000160220	15	25584333 - 25584336	15	25339186 - 25339189	160220	169078		NC_000015.10:25339185:TCTTT:T
NM_130839.5(UBE3A):c.1834_1837del (p.Ile612fs)	SNHG14|UBE3A	I195fs, I612fs, I175fs, I553fs, I615fs, I592fs	not provided|Angelman syndrome	Pathogenic(Last reviewed: Feb 1, 2019)	criteria provided, multiple submitters, no conflicts	VCV000160213	15	25601960 - 25601963	15	25356813 - 25356816	160213	169085	rs587784520	NC_000015.10:25356812:CAATCA:CA
NM_130839.5(UBE3A):c.1786_1790del (p.Phe596fs)	SNHG14|UBE3A	F179fs, F159fs, F596fs, F537fs, F576fs, F599fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160211	15	25602007 - 25602011	15	25356860 - 25356864	160211	169087	rs587784519	NC_000015.10:25356859:CAAAACAA:CAA
NM_130839.5(UBE3A):c.1521_1528del (p.Tyr508fs)	SNHG14|UBE3A	Y508fs, Y449fs, Y511fs, Y488fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160204	15	25615793 - 25615800	15	25370646 - 25370653	160204	169094	rs587784513	NC_000015.10:25370645:AGCTGTAGAG:AG
NM_130839.5(UBE3A):c.1170_1173del (p.Asn390fs)	SNHG14|UBE3A	N331fs, N393fs, N370fs, N390fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 8, 2013)	criteria provided, single submitter	VCV000160199	15	25616148 - 25616151	15	25371001 - 25371004	160199	169098	rs587784509	NC_000015.10:25371000:TTCATT:TT
NM_130839.5(UBE3A):c.*46del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156148	15	25584238	15	25339091	156148	165948	rs368425414	NC_000015.10:25339090:TTTTTTTTT:TTTTTTTT
NM_130839.5(UBE3A):c.2499-34del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156146	15	25584438	15	25339291	156146	165946	rs564915971	NC_000015.10:25339290:C:
NM_130839.5(UBE3A):c.63-19_63-17del	SNHG14|UBE3A		Angelman syndrome	Uncertain significance(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000156139	15	25620927 - 25620929	15	25375780 - 25375782	156139	165939	rs587782921	NC_000015.10:25375779:AACAA:AA
NM_130839.5(UBE3A):c.2616_*6del (p.Ter873GlnextTer?)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 22, 2016)	criteria provided, single submitter	VCV000155985	15	25584278 - 25584287	15	25339131 - 25339140	155985	165789	rs587781232	NC_000015.10:25339130:TTTGTTTTAC:
NM_130839.5(UBE3A):c.2567_2568del (p.Lys856fs)	SNHG14|UBE3A	K439fs, K797fs, K784fs, K804fs, K836fs, K856fs, K419fs, K781fs, K859fs	Angelman syndrome|not provided	Pathogenic/Likely pathogenic(Last reviewed: Apr 7, 2020)	criteria provided, multiple submitters, no conflicts	VCV000155984	15	25584335 - 25584336	15	25339188 - 25339189	155984	165788	rs587781231	NC_000015.10:25339187:TTT:T
NM_130839.5(UBE3A):c.2547_2614del (p.Ser850fs)	SNHG14|UBE3A	S775fs, S778fs, S830fs, S850fs, S413fs, S433fs, S791fs, S853fs, S798fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155980	15	25584289 - 25584356	15	25339142 - 25339209	155980	165784	rs1555379684	
NM_130839.5(UBE3A):c.2538del (p.Pro847fs)	SNHG14|UBE3A	P772fs, P795fs, P847fs, P410fs, P775fs, P827fs, P788fs, P850fs, P430fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155979	15	25584365	15	25339218	155979	165783	rs587781227	NC_000015.10:25339217:AA:A
NM_130839.5(UBE3A):c.2404_2405del (p.Phe802fs)	SNHG14|UBE3A	F730fs, F750fs, F805fs, F385fs, F727fs, F743fs, F365fs, F782fs, F802fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155975	15	25585325 - 25585326	15	25340178 - 25340179	155975	165779	rs587781224	NC_000015.10:25340177:AA:
NM_130839.5(UBE3A):c.2305del (p.Glu769fs)	SNHG14|UBE3A	E332fs, E769fs, E352fs, E697fs, E710fs, E717fs, E694fs, E749fs, E772fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155972	15	25599549	15	25354402	155972	165776	rs587781221	NC_000015.10:25354401:C:
NM_130839.5(UBE3A):c.2246del (p.Pro749fs)	SNHG14|UBE3A	P674fs, P729fs, P752fs, P690fs, P312fs, P332fs, P749fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155969	15	25599709	15	25354562	155969	165773	rs587781218	NC_000015.10:25354561:GG:G
NM_130839.5(UBE3A):c.2032del (p.Gln678fs)	SNHG14|UBE3A	Q678fs, Q681fs, Q658fs, Q241fs, Q261fs, Q619fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155965	15	25601131	15	25355984	155965	165769	rs587781214	NC_000015.10:25355983:GG:G
NM_130839.5(UBE3A):c.2016_2023del (p.Met673fs)	SNHG14|UBE3A	M653fs, M256fs, M614fs, M673fs, M236fs, M676fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155962	15	25601140 - 25601147	15	25355993 - 25356000	155962	165766	rs587781211	NC_000015.10:25355992:TCATCATGTCATC:TCATC
NM_130839.5(UBE3A):c.1874_1884del (p.Ile625fs)	SNHG14|UBE3A	I625fs, I566fs, I605fs, I188fs, I208fs, I628fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155960	15	25601913 - 25601923	15	25356766 - 25356776	155960	165764	rs587781209	NC_000015.10:25356765:TACATCCAGTATACA:TACA
NM_130839.5(UBE3A):c.1565_1566del (p.Leu522fs)	SNHG14|UBE3A	L463fs, L502fs, L522fs, L525fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155954	15	25615755 - 25615756	15	25370608 - 25370609	155954	165758	rs587781203	NC_000015.10:25370607:GAG:G
NM_130839.5(UBE3A):c.1447del (p.Ala483fs)	SNHG14|UBE3A	A424fs, A463fs, A483fs, A486fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155953	15	25615874	15	25370727	155953	165757	rs587781202	NC_000015.10:25370726:C:
NM_130839.5(UBE3A):c.1421_1422del (p.Phe474fs)	SNHG14|UBE3A	F415fs, F454fs, F474fs, F477fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000155951	15	25615899 - 25615900	15	25370752 - 25370753	155951	165755	rs587781200	NC_000015.10:25370751:AAAA:AA
NM_130839.5(UBE3A):c.1032_1038del (p.Thr345fs)	SNHG14|UBE3A	T286fs, T325fs, T345fs, T348fs	Inborn genetic diseases|Angelman syndrome	Pathogenic(Last reviewed: Sep 16, 2016)	criteria provided, single submitter	VCV000155943	15	25616283 - 25616289	15	25371136 - 25371142	155943	165747	rs587781192	NC_000015.10:25371135:ATAAGTAATAAGT:ATAAGT
NM_130839.5(UBE3A):c.1425_1439del (p.Met475_Phe479del)	SNHG14|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136208	15	25615882 - 25615896	15	25370735 - 25370749	136208	139912	rs587780585	NC_000015.10:25370734:ATAAAGGGACATGTCATAAA:ATAAA
NM_130839.5(UBE3A):c.607del (p.Asp203fs)	SNHG14|UBE3A	D144fs, D203fs, D183fs, D206fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136195	15	25616714	15	25371567	136195	139899	rs587780573	NC_000015.10:25371566:C:
NM_130839.5(UBE3A):c.337_340del (p.Lys113fs)	SNHG14|UBE3A	K93fs, K113fs, K116fs, K54fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136191	15	25620633 - 25620636	15	25375486 - 25375489	136191	139895	rs587780569	NC_000015.10:25375485:CTTTCTT:CTT
NM_130839.5(UBE3A):c.323_324del (p.Ile108fs)	SNHG14|UBE3A	I49fs, I88fs, I111fs, I108fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136189	15	25620649 - 25620650	15	25375502 - 25375503	136189	139893	rs587780567	NC_000015.10:25375501:TAT:T
NM_130839.5(UBE3A):c.159del (p.Cys54fs)	SNHG14|UBE3A	C34fs, C54fs, C57fs	Angelman syndrome	Pathogenic(Last reviewed: Feb 14, 2014)	no assertion criteria provided	VCV000136187	15	25620814	15	25375667	136187	139891	rs587780565	NC_000015.10:25375666:GG:G
NC_000015.10:g.(?_24566038)_(25781223_?)del	SNORD115-10|SNORD115-11|SNORD115-13|SNORD115-14|SNORD115-15|SNORD115-19|SNORD115-16|SNORD115-17|SNORD115-18|SNORD115-2|SNORD115-20|SNORD115-12|SNORD115-21|SNORD115-22|SNORD115-23|SNORD115-24|ATP10A|IPW|LINC02250|LOC112272578|LOC112272579|NPAP1|PWAR1|PWAR4|PWAR5|PWAR6|PWARSN|PWRN1|SNHG14|SNORD107|SNORD108|SNORD109A|SNORD109B|SNORD115-1|SNORD115-25|SNORD115-26|SNORD115-27|SNORD115-28|SNORD115-29|SNORD115-3|SNORD115-30|SNORD115-31|SNORD115-32|SNORD115-33|SNORD115-34|SNORD115-35|SNORD115-36|SNORD115-37|SNORD115-38|SNORD115-39|SNORD115-4|SNORD115-40|SNORD115-41|SNORD115-42|SNORD115-43|SNORD115-44|SNORD115-45|SNORD115-46|SNORD115-47|SNORD115-48|SNORD115-5|SNORD115-6|SNORD115-7|SNORD115-8|SNORD115-9|SNORD115@|SNORD116-1|SNORD116-10|SNORD116-11|SNORD116-12|SNORD116-13|SNORD116-14|SNORD116-15|SNORD116-16|SNORD116-17|SNORD116-18|SNORD116-19|SNORD116-2|SNORD116-20|SNORD116-21|SNORD116-22|SNORD116-23|SNORD116-24|SNORD116-25|SNORD116-26|SNORD116-27|SNORD116-28|SNORD116-29|SNORD116-3|SNORD116-30|SNORD116-4|SNORD116-5|SNORD116-6|SNORD116-7|SNORD116-8|SNORD116-9|SNORD116@|SNORD64|SNRPN|SNURF|UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 14, 2019)	criteria provided, single submitter	VCV000584203	15	24811185 - 26026370	15	24566038 - 25781223	584203	568553		
GRCh37/hg19 15q11.2(chr15:25582396-25684175)x1	UBE3A		Angelman syndrome	not provided	no assertion provided	VCV001177488	15	25582396 - 25684175			1177488	1166913		
NC_000015.9:g.(?_25584273)_(25650609_?)del	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Oct 24, 2020)	criteria provided, single submitter	VCV001069013	15	25584273 - 25650609			1069013	1057669		
UBE3A, 15-BP DEL/7-BP INS, NT3240	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Jan 1, 2010)	no assertion criteria provided	VCV000030204					30204	39160		
UBE3A, 2-BP DEL, 1930AG	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007971					7971	23010		
UBE3A, 4-BP DEL, 3093AAGA	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 30, 2004)	no assertion criteria provided	VCV000007970					7970	23009		
UBE3A, 2-BP DEL, 1344GT	UBE3A		Angelman syndrome	Pathogenic(Last reviewed: Apr 1, 1998)	no assertion criteria provided	VCV000007965					7965	23004		
